Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sacha Nahon-Esteve

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancers|November 11, 2020
Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and PerspectivesArnaud Martel, Stephanie Baillif, Sacha Nahon-Esteve, et al.
Annales De Pathologie|May 28, 2018
[Focus on clinical and pathological management of conjunctival melanocytic tumors]Sandra Lassalle, Jean-Pierre Caujolle, François Leger, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 14, 2025
Radiation-induced maculopathy and fluocinolone acetonide implantJules Fricker, Sacha Nahon-Esteve, Sarah Tick, et al.
International Journal of Molecular Sciences|December 3, 2020
PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical OutcomeSandra Lassalle, Sacha Nahon-Esteve, Eric Frouin, et al.
Cancers|July 2, 2021
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New 'Eye-Sparing' Paradigm?Arnaud Martel, Sandra Lassalle, Alexandra Picard-Gauci, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
Benefit of Optical Coherence Tomography-Angiography in Patients Undergoing Transsphenoidal Pituitary Adenoma Surgery: A Prospective Controlled StudyElsa Toumi, Fabien Almairac, Lydiane Mondot, et al.
International Journal of Molecular Sciences|July 14, 2023
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical PracticeArnaud Martel, Baharia Mograbi, Barnabe Romeo, et al.
Cancers|May 16, 2023
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) BiobankArnaud Martel, Lauris Gastaud, Christelle Bonnetaud, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancers|November 11, 2020
Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and PerspectivesArnaud Martel, Stephanie Baillif, Sacha Nahon-Esteve, et al.
Annales De Pathologie|May 28, 2018
[Focus on clinical and pathological management of conjunctival melanocytic tumors]Sandra Lassalle, Jean-Pierre Caujolle, François Leger, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 14, 2025
Radiation-induced maculopathy and fluocinolone acetonide implantJules Fricker, Sacha Nahon-Esteve, Sarah Tick, et al.
International Journal of Molecular Sciences|December 3, 2020
PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical OutcomeSandra Lassalle, Sacha Nahon-Esteve, Eric Frouin, et al.
Cancers|July 2, 2021
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New 'Eye-Sparing' Paradigm?Arnaud Martel, Sandra Lassalle, Alexandra Picard-Gauci, et al.
Diagnostics (Basel, Switzerland)|August 29, 2024
Benefit of Optical Coherence Tomography-Angiography in Patients Undergoing Transsphenoidal Pituitary Adenoma Surgery: A Prospective Controlled StudyElsa Toumi, Fabien Almairac, Lydiane Mondot, et al.
International Journal of Molecular Sciences|July 14, 2023
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical PracticeArnaud Martel, Baharia Mograbi, Barnabe Romeo, et al.
Cancers|May 16, 2023
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) BiobankArnaud Martel, Lauris Gastaud, Christelle Bonnetaud, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
Pageof 2